Deutsche Bank’s Acutus Medical Inc AFIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-44,012
Closed -$61K 4381
2022
Q1
$61K Buy
44,012
+32,030
+267% +$68.5K ﹤0.01% 3769
2021
Q4
$41K Buy
11,982
+624
+5% +$3.51K ﹤0.01% 4010
2021
Q3
$100K Buy
11,358
+2,203
+24% +$29K ﹤0.01% 3907
2021
Q2
$155K Sell
9,155
-289
-3% -$4.23K ﹤0.01% 3928
2021
Q1
$126K Buy
9,444
+2,066
+28% +$46.5K ﹤0.01% 3856
2020
Q4
$212K Buy
7,378
+2,083
+39% +$56.4K ﹤0.01% 3441
2020
Q3
$158K Buy
+5,295
New +$161K ﹤0.01% 3340

Other funds holding AFIB

Deutsche Bank's AFIB Position: Q2 2022 in Review

Deutsche Bank sold out of Acutus Medical Inc (AFIB) in Q2 2022, closing a stake of 44,012 shares — an estimated $61K sold.

Deutsche Bank first reported a position in AFIB in Q3 2020 and held it in 7 quarters. The position peaked at $212K in Q4 2020. 47 funds tracked by Wall St. Rank hold AFIB as of Q2 2022.

  • Deutsche Bank reported no remaining Acutus Medical Inc position as of Q2 2022 after selling out during the quarter.
  • Deutsche Bank sold 44,012 Acutus Medical Inc shares in Q2 2022, an estimated $61K.
  • Deutsche Bank first reported a position in Acutus Medical Inc in Q3 2020 and held it in 7 quarters.
  • Deutsche Bank's Acutus Medical Inc position peaked at $212K in Q4 2020.
  • 47 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q2 2022.

Based on Deutsche Bank's 13F filing for Q2 2022, filed 11 Aug 2022.